UDK: 616.379-008.64-085.31

Clinical experience of administering ateroblock and aktalipid to dyslipidemic patients with type 2 diabetes

M. E. Statsenko, S. V. Turkina, L. I. Inina

Волгоградский государственный медицинский университет, кафедра внутренних болезней педиатрического и стоматологического факультетов

Abstract

Results of our study indicate that combined hypolipidemic therapy with Ateroblock and Aktalipid proved effective and safe for patients with diabetes type 2 with ischemic heart disease and hypertension.

Keywords

diabetes, dyslipidemia, Ateroblok, Aktalipid, aspartic and alanine amino transferase, Bilirubin in blood serum, serum creatinine, creatinine clearance

Contacts